TRxADE HEALTH, Inc. (MEDS)
NASDAQ: MEDS · IEX Real-Time Price · USD
14.74
-6.18 (-29.54%)
At close: Jul 19, 2024, 4:00 PM
15.21
+0.47 (3.19%)
Pre-market: Jul 22, 2024, 5:32 AM EDT
TRxADE HEALTH Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for TRxADE HEALTH.
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for TRxADE HEALTH.
Recommendation Trends
| Rating | Feb '23 | Mar '23 | Apr '23 | May '23 | Jun '23 |
|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 2 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 2 | 0 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| EF Hutton | EF Hutton | Strong Buy Initiates $19 | Strong Buy | Initiates | $19 | +27.20% | Jun 1, 2023 |
| EF Hutton | EF Hutton | Strong Buy Maintains $26 → $19 | Strong Buy | Maintains | $26 → $19 | +27.20% | May 16, 2023 |
| Maxim Group | Maxim Group | Strong Buy Maintains $38 → $26 | Strong Buy | Maintains | $38 → $26 | +78.09% | Mar 28, 2023 |
| EF Hutton | EF Hutton | Strong Buy Initiates n/a | Strong Buy | Initiates | n/a | n/a | Dec 9, 2021 |
Financial Forecast
Revenue This Year
9.49M
from 8.27M
Increased by 14.67%
Revenue Next Year
n/a
from 9.49M
EPS This Year
-0.46
from -7.49
EPS Next Year
n/a
from -0.46
Revenue Forecast
| Revenue | 2024 |
|---|---|
| High | 9.8M |
| Avg | 9.5M |
| Low | 9.1M |
Revenue Growth
| Revenue Growth | 2024 |
|---|---|
| High | 18.0% |
| Avg | 14.7% |
| Low | 10.2% |
EPS Forecast
| EPS | 2024 |
|---|---|
| High | -0.47 |
| Avg | -0.46 |
| Low | -0.44 |
EPS Growth
| EPS Growth | 2024 |
|---|---|
| High | - |
| Avg | - |
| Low | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.